5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      High Attenuation Areas on Chest CT in Community-Dwelling Adults: The MESA Study

      research-article
      , MD 1 , , MD 1 , , MD 1 , 2 , , PhD 3 , , MPhil 2 , , MD 4 , , MD 1 , , MD 5 , , MD 6 , , MD 7 , , MD 8 , , MS 9 , , MD 10 , , MD 11 , , MD 3 , , MD 12 , , PhD 13 , , MD 10 , , MPH 1 , 14 , , MD 11 , , PhD 15 , , MD 11 , , MPH 10 , , MD 16 , , MD 1 , 2
      The European respiratory journal

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evidence suggests that lung injury, inflammation and extracellular matrix remodeling precede lung fibrosis in interstitial lung disease (ILD). We examined whether a quantitative measure of increased lung attenuation on computed tomography (CT) detects lung injury, inflammation and extracellular matrix remodeling in community-dwelling adults sampled without regard to respiratory symptoms or smoking.

          We measured high attenuation areas (HAA; percentage of lung voxels between -600 and -250 Hounsfield Units) on cardiac CT scans of adults enrolled in the Multi-Ethnic Study of Atherosclerosis.

          HAA was associated with higher serum matrix metalloproteinase-7 (mean adjusted difference 6.3% per HAA doubling, 95% CI 1.3 to 11.5), higher interleukin-6 (mean adjusted difference 8.8%, 95% CI 4.8 to 13.0), lower forced vital capacity (mean adjusted difference -82 mL, 95% CI -119 to -44), lower 6-minute walk distance (mean adjusted difference -40 m, 95% CI -1 to -80), higher odds of interstitial lung abnormalities at 9.5 years (adjusted OR 1.95, 95% CI 1.43 to 2.65), and higher all cause-mortality rate over 12.2 years (HR 1.58, 95% CI 1.39 to 1.79).

          High attenuation areas are associated with biomarkers of inflammation and extracellular matrix remodeling, reduced lung function, interstitial lung abnormalities, and a higher risk of death among community-dwelling adults.

          Related collections

          Author and article information

          Journal
          8803460
          3682
          Eur Respir J
          Eur. Respir. J.
          The European respiratory journal
          0903-1936
          1399-3003
          15 June 2016
          28 July 2016
          November 2016
          01 November 2017
          : 48
          : 5
          : 1442-1452
          Affiliations
          [1 ]Department of Medicine, Columbia University Medical Center, 161 Fort Washington, New York, NY, USA
          [2 ]Department of Epidemiology, Columbia University Medical Center, 161 Fort Washington, New York, NY, USA
          [3 ]Departments of Radiology, Medicine, and Biomedical Engineering, University of Iowa Carver College of Medicine, 451 Newton Road, Iowa City, IA, USA
          [4 ]Department of Radiology, Columbia University Medical Center, 161 Fort Washington, New York, NY, USA
          [5 ]Department of Rehabilitation Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, 111 East 210th Street, Bronx, NY, USA
          [6 ]Department of Medicine and the Center for Translational Lung Biology, University of Pennsylvania, 423 Guardian Drive, 717 Blockley Hall, Philadelphia, PA, USA
          [7 ]Department of Epidemiology, University of Arizona, 1295 N. Martin Ave, PO Box 245163, Tucson, AZ, USA
          [8 ]National Human Genome Research Institute, 10 Center Dr, Bethesda, MD, USA
          [9 ]Department of Biostatistics, University of Washington, 4225 Roosevelt Way NE, Seattle, WA, USA
          [10 ]Department of Medicine, University of Washington, 4225 Roosevelt Way NE, Seattle, WA, USA
          [11 ]Department of Radiology, University of Alabama, Jefferson Tower, Room N370, 625 19th Street, South Birmingham, AL, USA
          [12 ]Duke Clinical Research Institute, Duke University, 2085 Msrb2 2 Genome Ct, Durham, NC, USA
          [13 ]Department of Statistics, Columbia University, 161 Fort Washington, New York, NY, USA
          [14 ]VIDA Diagnostics, Inc., 2500 Crosspark Rd, W250 BioVentures Center, Coralville, IA, USA
          [15 ]Department of Pathology, University of Vermont, 360 South Park Drive, Colchester, VT, USA
          [16 ]Department of Medicine and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, 423 Guardian Drive, 718 Blockley Hall, Philadelphia, PA, USA
          Author notes
          Corresponding Author: David J Lederer, MD, MS, Associate Professor of Medicine and Epidemiology, Columbia University Medical Center, 161 Fort Washington Ave, Room 3-321A, New York, NY 10032, Phone: 212-305-8203, Fax: 212-305-8426, davidlederer@ 123456columbia.edu
          [*]

          These authors contributed equally to this work

          Article
          PMC5089905 PMC5089905 5089905 nihpa795152
          10.1183/13993003.00129-2016
          5089905
          27471206
          497592e4-26f7-47e4-9ba3-58d4b9d49b9e
          History
          Categories
          Article

          Comments

          Comment on this article